Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
Cancer Cell International|July 31, 2015
Mechanistic attributes of S100A7 (psoriasin) in resistance of anoikis resulting tumor progression in squamous cell carcinoma of the oral cavityKaushik Kumar Dey, Siddik Sarkar, Ipsita Pal, et al.ACS Biomaterials Science & Engineering|January 6, 2021
Osteochondral Defects Healing Using Extracellular Matrix Mimetic Phosphate/Sulfate Decorated GAGs-Agarose Gel and Quantitative Micro-CT EvaluationKausik Kapat, Arun Prabhu Rameshbabu, Priti Prasanna Maity, et al.Acta Biomaterialia|April 26, 2016
Paclitaxel-loaded solid lipid nanoparticles modified with Tyr-3-octreotide for enhanced anti-angiogenic and anti-glioma therapyIndranil Banerjee, Kakali De, Dibyanti Mukherjee, et al.Cellular Signalling|March 29, 2017
Therapeutic implication of 'Iturin A' for targeting MD-2/TLR4 complex to overcome angiogenesis and invasionGoutam Dey, Rashmi Bharti, Probir Kumar Ojha, et al.Drug Delivery|February 7, 2017
Successful delivery of docetaxel to rat brain using experimentally developed nanoliposome: a treatment strategy for brain tumorTapan Kumar Shaw, Dipika Mandal, Goutam Dey, et al.Cancer Cell International|October 13, 2015
Erratum to: Mechanistic attributes of S100A7 (psoriasin) in resistance of anoikis resulting tumor progression in squamous cell carcinoma of the oral cavityKaushik Kumar Dey, Siddik Sarkar, Ipsita Pal, et al.Molecular Pharmaceutics|October 28, 2015
Overcoming Akt Induced Therapeutic Resistance in Breast Cancer through siRNA and Thymoquinone Encapsulated Multilamellar Gold NiosomesShashi Rajput, Nagaprasad Puvvada, B N Prashanth Kumar, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 11, 2015
Identification of RAB2A and PRDX1 as the potential biomarkers for oral squamous cell carcinoma using mass spectrometry-based comparative proteomic approachKaushik Kumar Dey, Ipsita Pal, Rashmi Bharti, et al.Journal of Ovarian Research|June 27, 2023
LCK facilitates DNA damage repair by stabilizing RAD51 and BRCA1 in the nucleus of chemoresistant ovarian cancerGoutam Dey, Rashmi Bharti, Chad Braley, et al.Science Advances|June 13, 2025
Leveraging dysregulated tumor metabolism for targeting anticancer bacteriaAkeem Santos, Zeneng Wang, Rashmi Bharti, et al.Pageof 4